InsiderTrades.com logo

ALNY Insider Trading

Insider Ownership Percentage: 1.50%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $85,644,402.94

Alnylam Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Alnylam Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Alnylam Pharmaceuticals Share Price & Price History

Current Price: $328.16
Price Change: ▼ Price Decrease of -3.08 (-0.93%)
As of 02/6/2026 05:00 PM ET

This chart shows the closing price history over time for ALNY up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Alnylam Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/13/2026Kevin Joseph FitzgeraldEVPSell2,290$370.33$848,055.7021,264View SEC Filing Icon  
1/12/2026Jeffrey V. PoultonEVPSell2,780$362.87$1,008,778.6057,465View SEC Filing Icon  
1/12/2026Kevin Joseph FitzgeraldEVPSell1,510$362.87$547,933.7023,554View SEC Filing Icon  
1/12/2026Pushkal GargEVPSell1,510$362.87$547,933.7022,511View SEC Filing Icon  
1/12/2026Tolga TangulerEVPSell1,510$362.87$547,933.7029,728View SEC Filing Icon  
1/12/2026Yvonne GreenstreetCEOSell9,577$362.86$3,475,110.2278,411View SEC Filing Icon  
11/17/2025Kevin Joseph FitzgeraldEVPSell12,128$452.18$5,484,039.0421,264View SEC Filing Icon  
11/13/2025Yvonne GreenstreetCEOSell10,000$451.27$4,512,700.0065,409View SEC Filing Icon  
11/12/2025Yvonne GreenstreetCEOSell15,650$453.69$7,100,248.5065,409View SEC Filing Icon  
10/3/2025Pushkal GargEVPSell3,022$451.48$1,364,372.5620,221View SEC Filing Icon  
10/2/2025Jeffrey V. PoultonEVPSell3,821$452.05$1,727,283.0554,052View SEC Filing Icon  
10/2/2025Kevin Joseph FitzgeraldEVPSell2,441$452.05$1,103,454.0525,231View SEC Filing Icon  
10/2/2025Pushkal GargEVPSell2,937$452.05$1,327,670.8523,243View SEC Filing Icon  
10/2/2025Tolga TangulerEVPSell1,405$452.05$635,130.2527,438View SEC Filing Icon  
10/2/2025Yvonne GreenstreetCEOSell8,924$452.05$4,034,094.2065,409View SEC Filing Icon  
9/9/2025Colleen F. ReitanDirectorSell18,000$467.60$8,416,800.00775View SEC Filing Icon  
8/19/2025Pushkal GargEVPSell1,455$458.41$666,986.5520,221View SEC Filing Icon  
8/18/2025Jeffrey V. PoultonEVPSell2,274$453.27$1,030,735.9850,121View SEC Filing Icon  
8/18/2025Kevin Joseph FitzgeraldEVPSell1,396$453.27$632,764.9222,719View SEC Filing Icon  
8/18/2025Michael W. BonneyDirectorSell11,250$450.00$5,062,500.0016,804View SEC Filing Icon  
8/18/2025Pushkal GargEVPSell1,396$453.27$632,764.9221,676View SEC Filing Icon  
8/18/2025Tolga TangulerEVPSell1,396$453.27$632,764.9229,466View SEC Filing Icon  
8/18/2025Yvonne GreenstreetCEOSell6,979$453.27$3,163,371.3356,221View SEC Filing Icon  
8/14/2025Dennis A. AusielloDirectorSell31,448$436.58$13,729,567.84911View SEC Filing Icon  
6/2/2025Yvonne GreenstreetCEOSell19,297$306.00$5,904,882.0048,948View SEC Filing Icon  
5/30/2025Yvonne GreenstreetCEOSell31,640$304.39$9,630,899.6048,948View SEC Filing Icon  
2/18/2025Kevin Joseph FitzgeraldEVPSell1,440$251.56$362,246.4012,881View SEC Filing Icon  
2/18/2025Pushkal GargCMOSell1,548$251.67$389,585.1611,989View SEC Filing Icon  
2/14/2025Jeffrey V. PoultonCFOSell967$255.17$246,749.3932,786View SEC Filing Icon  
2/14/2025Kevin Joseph FitzgeraldEVPSell663$255.21$169,204.2314,321View SEC Filing Icon  
2/14/2025Pushkal GargCMOSell1,561$255.17$398,320.3713,537View SEC Filing Icon  
2/14/2025Yvonne GreenstreetCEOSell1,213$255.17$309,521.2181,526View SEC Filing Icon  
1/27/2025Pushkal GargCMOSell52,592$285.00$14,988,720.0011,989View SEC Filing Icon  
1/23/2025Phillip A. SharpDirectorSell11,250$275.00$3,093,750.00View SEC Filing Icon  
12/12/2024Pushkal GargCMOSell1,752$251.00$439,752.0015,705View SEC Filing Icon  
11/26/2024Pushkal GargCMOSell1,682$250.98$422,148.3617,457View SEC Filing Icon  
11/26/2024Tolga TangulerEVPSell1,469$250.98$368,689.6213,191View SEC Filing Icon  
11/26/2024Yvonne GreenstreetCEOSell5,219$250.98$1,309,864.6278,880View SEC Filing Icon  
8/20/2024Yvonne GreenstreetCEOSell15,000$280.00$4,200,000.0073,441View SEC Filing Icon  
8/6/2024Dennis A. AusielloDirectorSell20,250$262.00$5,305,500.00136View SEC Filing Icon  
8/1/2024Yvonne GreenstreetCEOSell15,148$270.00$4,089,960.0073,441View SEC Filing Icon  
7/11/2024Yvonne GreenstreetCEOSell7,093$261.00$1,851,273.0073,441View SEC Filing Icon  
6/25/2024Jeffrey V. PoultonCFOSell1,605$231.00$370,755.0028,892View SEC Filing Icon  
6/25/2024Kevin Joseph FitzgeraldEVPSell1,198$230.99$276,726.0214,181View SEC Filing Icon  
6/25/2024Pushkal GargCMOSell2,103$230.99$485,771.9715,609View SEC Filing Icon  
6/25/2024Yvonne GreenstreetCEOSell8,301$230.99$1,917,447.9980,534View SEC Filing Icon  
6/24/2024David E. I. PyottDirectorSell32,450$220.69$7,161,390.50136View SEC Filing Icon  
5/29/2024Amy W. SchulmanDirectorSell21,700$148.60$3,224,620.008,436View SEC Filing Icon  
12/27/2023Michael W. BonneyDirectorSell30,000$195.00$5,850,000.0016,029View SEC Filing Icon  
8/7/2023Pushkal GargCMOSell4,166$183.89$766,085.744,345View SEC Filing Icon  
8/4/2023Jeffrey V. PoultonCFOSell3,460$185.85$643,041.0015,873View SEC Filing Icon  
8/4/2023Pushkal GargCMOSell3,461$185.85$643,226.858,511View SEC Filing Icon  
8/4/2023Yvonne GreenstreetCEOSell4,057$185.85$753,993.4535,216View SEC Filing Icon  
4/27/2023Akshay VaishnawPresidentSell2,392$194.59$465,459.2817,890View SEC Filing Icon  
4/27/2023Jeffrey V. PoultonCFOSell977$194.59$190,114.4311,706View SEC Filing Icon  
4/27/2023Pushkal GargCMOSell1,839$194.59$357,851.016,800View SEC Filing Icon  
4/27/2023Tolga TangulerEVPSell1,476$194.59$287,214.841,801View SEC Filing Icon  
4/27/2023Yvonne GreenstreetCEOSell7,615$194.59$1,481,802.8530,332View SEC Filing Icon  
4/6/2023Indrani Lall FranchiniEVPSell3,500$210.00$735,000.00View SEC Filing Icon  
3/3/2023Pushkal GargCMOSell18,072$200.00$3,614,400.004,345View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Alnylam Pharmaceuticals (NASDAQ:ALNY)

92.97% of Alnylam Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ALNY by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Alnylam Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/6/2026EverSource Wealth Advisors LLC1,061$0.42M0.0%-6.1%0.001%Search for SEC Filing on Google Icon
2/6/2026Evoke Wealth LLC621$0.25M0.0%-30.7%0.000%Search for SEC Filing on Google Icon
2/6/2026Mizuho Markets Cayman LP24,958$9.93M0.5%N/A0.019%Search for SEC Filing on Google Icon
2/6/2026Global Retirement Partners LLC1,856$0.74M0.0%+313.4%0.001%Search for SEC Filing on Google Icon
2/6/2026Twin Capital Management Inc.2,208$0.88M0.1%N/A0.002%Search for SEC Filing on Google Icon
2/6/2026Leonteq Securities AG105$42K0.0%N/A0.000%Search for SEC Filing on Google Icon
2/6/2026ABN Amro Investment Solutions5,759$2.29M0.0%+339.6%0.004%Search for SEC Filing on Google Icon
2/6/2026IFP Advisors Inc664$0.26M0.0%+35.2%0.001%Search for SEC Filing on Google Icon
2/6/2026PSP Research LLC1,318$0.52M0.5%N/A0.001%Search for SEC Filing on Google Icon
2/6/2026Intrust Bank NA538$0.21M0.0%N/A0.000%Search for SEC Filing on Google Icon
2/6/2026Banque Cantonale Vaudoise11,037$4.39M0.2%+127.1%0.008%Search for SEC Filing on Google Icon
2/6/2026Covestor Ltd63$25K0.0%-76.8%0.000%Search for SEC Filing on Google Icon
2/6/2026Fideuram Intesa Sanpaolo Private Banking S.P.A.20,482$8.15M0.3%N/A0.016%Search for SEC Filing on Google Icon
2/6/2026PNC Financial Services Group Inc.12,678$5.04M0.0%-3.3%0.010%Search for SEC Filing on Google Icon
2/6/2026Tredje AP fonden40,447$16.08M0.1%+200.6%0.031%Search for SEC Filing on Google Icon
2/6/2026Larson Financial Group LLC241$96K0.0%-19.7%0.000%Search for SEC Filing on Google Icon
2/6/2026Handelsbanken Fonder AB136,185$54.15M0.2%-12.3%0.103%Search for SEC Filing on Google Icon
2/6/2026Resona Asset Management Co. Ltd.39,247$15.61M0.1%-5.4%0.030%Search for SEC Filing on Google Icon
2/6/2026Capstone Capital Management Ltd2,301$0.92M0.9%N/A0.002%Search for SEC Filing on Google Icon
2/6/2026Profund Advisors LLC15,589$6.20M0.2%+340.9%0.012%Search for SEC Filing on Google Icon
2/6/2026ProShare Advisors LLC211,077$83.94M0.1%+4,457.9%0.160%Search for SEC Filing on Google Icon
2/6/2026HighTower Advisors LLC106,491$42.35M0.0%-3.7%0.081%Search for SEC Filing on Google Icon
2/6/2026Envestnet Portfolio Solutions Inc.4,345$1.73M0.0%+227.4%0.003%Search for SEC Filing on Google Icon
2/6/2026Cascade Financial Partners LLC523$0.21M0.0%-16.6%0.000%Search for SEC Filing on Google Icon
2/5/2026Gabelli Funds LLC550$0.22M0.0%-100.0%0.000%Search for SEC Filing on Google Icon
2/5/2026North Dakota State Investment Board4,789$1.90M0.1%N/A0.004%Search for SEC Filing on Google Icon
2/5/2026Soltis Investment Advisors LLC530$0.21M0.0%N/A0.000%Search for SEC Filing on Google Icon
2/5/2026iA Global Asset Management Inc.17,780$7.07M0.1%+979.5%0.013%Search for SEC Filing on Google Icon
2/5/2026Beese Fulmer Investment Management Inc.888$0.35M0.0%N/A0.001%Search for SEC Filing on Google Icon
2/5/2026AlphaCore Capital LLC527$0.21M0.0%N/A0.000%Search for SEC Filing on Google Icon
2/5/2026DNB Asset Management AS30,707$12.21M0.0%-10.4%0.023%Search for SEC Filing on Google Icon
2/5/2026ANTIPODES PARTNERS Ltd47,886$19.04M0.4%+49.8%0.036%Search for SEC Filing on Google Icon
2/5/2026Northwestern Mutual Wealth Management Co.6,234$2.48M0.0%+999.5%0.005%Search for SEC Filing on Google Icon
2/5/2026AustralianSuper Pty Ltd4,803$1.91M0.0%-16.4%0.004%Search for SEC Filing on Google Icon
2/5/2026SkyOak Wealth LLC760$0.30M0.1%-10.3%0.001%Search for SEC Filing on Google Icon
2/5/2026Thrivent Financial for Lutherans20,641$8.21M0.0%N/A0.016%Search for SEC Filing on Google Icon
2/5/2026New York Life Investment Management LLC1,745$0.69M0.0%+7.1%0.001%Search for SEC Filing on Google Icon
2/5/2026E Fund Management Hong Kong Co. Ltd.389$0.16M0.1%N/A0.000%Search for SEC Filing on Google Icon
2/5/2026Allworth Financial LP1,353$0.54M0.0%+4.9%0.001%Search for SEC Filing on Google Icon
2/4/2026Independent Advisor Alliance605$0.24M0.0%-10.9%0.000%Search for SEC Filing on Google Icon
2/4/2026Atlantic Union Bankshares Corp231$92K0.0%+20.9%0.000%Search for SEC Filing on Google Icon
2/4/2026HighPoint Advisor Group LLC832$0.33M0.0%+18.2%0.001%Search for SEC Filing on Google Icon
2/4/2026AG2R LA Mondiale Gestion D Actifs5,595$2.23M0.1%-3.9%0.004%Search for SEC Filing on Google Icon
2/4/2026Swiss Life Asset Management Ltd22,472$8.94M0.0%+4.4%0.017%Search for SEC Filing on Google Icon
2/4/2026Plato Investment Management Ltd6,254$2.50M0.2%+27.5%0.005%Search for SEC Filing on Google Icon
2/3/2026NewEdge Wealth LLC7,530$2.99M0.0%-5.8%0.006%Search for SEC Filing on Google Icon
2/3/2026Crossmark Global Holdings Inc.1,281$0.51M0.0%+4.7%0.001%Search for SEC Filing on Google Icon
2/3/2026Ethic Inc.3,218$1.28M0.0%+47.3%0.002%Search for SEC Filing on Google Icon
2/3/2026Ballentine Partners LLC1,721$0.68M0.0%+3.6%0.001%Search for SEC Filing on Google Icon
2/3/2026Orion Capital Management LLC2,967$1.18M0.4%-5.5%0.002%Search for SEC Filing on Google Icon
2/3/2026ASR Vermogensbeheer N.V.11,022$4.38M0.1%+24.2%0.008%Search for SEC Filing on Google Icon
2/3/2026MGO One Seven LLC833$0.33M0.0%+19.0%0.001%Search for SEC Filing on Google Icon
2/3/2026Sequoia Financial Advisors LLC4,212$1.68M0.0%-2.2%0.003%Search for SEC Filing on Google Icon
2/3/2026S Bank Fund Management Ltd1,281$0.51M0.1%-19.6%0.001%Search for SEC Filing on Google Icon
2/3/2026Swedbank AB61,942$24.63M0.0%-2.6%0.047%Search for SEC Filing on Google Icon
2/3/2026Mitsubishi UFJ Asset Management Co. Ltd.138,795$55.54M0.0%+14.9%0.105%Search for SEC Filing on Google Icon
2/3/2026Bronte Capital Management Pty Ltd.38,864$15.45M1.7%+11.1%0.029%Search for SEC Filing on Google Icon
2/3/2026Sumitomo Mitsui DS Asset Management Company Ltd15,869$6.31M0.0%+0.3%0.012%Search for SEC Filing on Google Icon
2/3/2026SBI Securities Co. Ltd.147$58K0.0%+133.3%0.000%Search for SEC Filing on Google Icon
2/2/2026QRG Capital Management Inc.2,363$0.94M0.0%-3.0%0.002%Search for SEC Filing on Google Icon
2/2/2026Varma Mutual Pension Insurance Co26,100$10.38M0.1%N/A0.020%Search for SEC Filing on Google Icon
2/2/2026Truist Financial Corp6,105$2.43M0.0%-5.6%0.005%Search for SEC Filing on Google Icon
2/2/2026PKO Investment Management Joint Stock Co6,800$2.70M0.2%+750.0%0.005%Search for SEC Filing on Google Icon
2/2/2026Hussman Strategic Advisors Inc.6,300$2.51M0.6%N/A0.005%Search for SEC Filing on Google Icon
2/2/2026Benjamin Edwards Inc.733$0.29M0.0%+50.5%0.001%Search for SEC Filing on Google Icon
2/2/2026Strs Ohio28,036$11.15M0.0%+0.2%0.021%Search for SEC Filing on Google Icon
2/2/2026Ashton Thomas Securities LLC688$0.27M0.1%N/A0.001%Search for SEC Filing on Google Icon
2/2/2026Cornerstone Planning Group LLC95$38K0.0%-80.7%0.000%Search for SEC Filing on Google Icon
2/2/2026Kornitzer Capital Management Inc. KS11,114$4.42M0.1%-53.1%0.008%Search for SEC Filing on Google Icon
2/2/2026PFA Pension Forsikringsaktieselskab35,405$14.07M0.0%N/A0.027%Search for SEC Filing on Google Icon
2/2/2026Horizon Investments LLC451$0.18M0.0%+11.9%0.000%Search for SEC Filing on Google Icon
2/2/2026Robertson Stephens Wealth Management LLC2,800$1.11M0.0%N/A0.002%Search for SEC Filing on Google Icon
2/2/2026Fifth Third Bancorp127$51K0.0%-97.5%0.000%Search for SEC Filing on Google Icon
2/2/2026Danske Bank A S67,201$26.72M0.1%+17.1%0.051%Search for SEC Filing on Google Icon
2/2/2026GenTrust LLC695$0.28M0.0%N/A0.001%Search for SEC Filing on Google Icon
2/2/2026Oppenheimer & Co. Inc.966$0.38M0.0%-43.7%0.001%Search for SEC Filing on Google Icon
1/30/2026Activest Wealth Management108$43K0.0%+10,700.0%0.000%Search for SEC Filing on Google Icon
1/30/2026Jennison Associates LLC277,759$110.45M0.1%-8.9%0.210%Search for SEC Filing on Google Icon
1/30/2026State of New Jersey Common Pension Fund D44,976$17.89M0.1%-1.2%0.034%Search for SEC Filing on Google Icon
1/30/2026Keybank National Association OH3,335$1.33M0.0%-17.9%0.003%Search for SEC Filing on Google Icon
1/30/2026FengHe Fund Management Pte. Ltd.218,700$86.97M4.9%N/A0.166%Search for SEC Filing on Google Icon
1/30/2026Wealthfront Advisers LLC18,254$7.26M0.0%+36.0%0.014%Search for SEC Filing on Google Icon
1/30/2026Values First Advisors Inc.3,226$1.28M0.7%-16.9%0.002%Search for SEC Filing on Google Icon
1/30/2026Torren Management LLC235$93K0.0%N/A0.000%Search for SEC Filing on Google Icon
1/30/2026Mitsubishi UFJ Trust & Banking Corp79,397$31.57M0.1%+2.5%0.060%Search for SEC Filing on Google Icon
1/30/2026M&T Bank Corp7,966$3.17M0.0%+17.1%0.006%Search for SEC Filing on Google Icon
1/29/2026Comerica Bank4,040$1.61M0.0%-65.7%0.003%Search for SEC Filing on Google Icon
1/29/2026Pictet Asset Management Holding SA316,053$125.78M0.1%-18.4%0.239%Search for SEC Filing on Google Icon
1/29/2026ST Germain D J Co. Inc.7,857$3.12M0.1%-3.6%0.006%Search for SEC Filing on Google Icon
1/29/2026Sanctuary Advisors LLC6,520$2.59M0.0%+5.6%0.005%Search for SEC Filing on Google Icon
1/29/2026Teachers Retirement System of The State of Kentucky31,616$12.57M0.1%-3.7%0.024%Search for SEC Filing on Google Icon
1/29/2026Vanguard Group Inc.13,553,932$5.39B0.1%-0.1%10.260%Search for SEC Filing on Google Icon
1/29/2026Munich Reinsurance Co Stock Corp in Munich275$0.11M0.0%N/A0.000%Search for SEC Filing on Google Icon
1/29/2026Sava Infond d.o.o.1,285$0.51M0.1%-21.6%0.001%Search for SEC Filing on Google Icon
1/29/2026Concurrent Investment Advisors LLC802$0.32M0.0%N/A0.001%Search for SEC Filing on Google Icon
1/29/2026Generali Investments Management Co LLC965$0.38M0.1%N/A0.001%Search for SEC Filing on Google Icon
1/29/2026China Universal Asset Management Co. Ltd.25,267$10.05M0.8%+10.9%0.019%Search for SEC Filing on Google Icon
1/29/2026Rakuten Securities Inc.189$75K0.0%+4,625.0%0.000%Search for SEC Filing on Google Icon
1/28/2026Arizona State Retirement System36,390$14.47M0.1%-5.5%0.028%Search for SEC Filing on Google Icon
1/28/2026waypoint wealth counsel895$0.36M0.1%+44.1%0.001%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Alnylam Pharmaceuticals logo
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Read More on Alnylam Pharmaceuticals

Today's Range

Now: $328.16
Low: $326.51
High: $340.07

50 Day Range

MA: $389.54
Low: $328.16
High: $473.29

52 Week Range

Now: $328.16
Low: $205.87
High: $495.55

Volume

1,476,701 shs

Average Volume

1,606,979 shs

Market Capitalization

$43.35 billion

P/E Ratio

1,367.33

Dividend Yield

N/A

Beta

0.35

Who are the company insiders with the largest holdings of Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals' top insider investors include:
  1. Yvonne Greenstreet (CEO)
  2. Jeffrey V Poulton (EVP)
  3. Jeffrey V Poulton (CFO)
  4. Tolga Tanguler (EVP)
  5. Kevin Joseph Fitzgerald (EVP)
  6. Pushkal Garg (EVP)
  7. Pushkal Garg (CMO)
  8. Michael W Bonney (Director)
  9. Amy W Schulman (Director)
  10. Dennis A Ausiello (Director)
  11. Colleen F Reitan (Director)
  12. David E I Pyott (Director)
  13. Phillip A Sharp (Director)
Learn More about top insider investors at Alnylam Pharmaceuticals.

Who are the major institutional investors of Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals' top institutional shareholders include:
  1. Vanguard Group Inc. — 10.26%
  2. Baillie Gifford & Co. — 1.97%
  3. Massachusetts Financial Services Co. MA — 0.37%
  4. KBC Group NV — 0.26%
  5. Sumitomo Mitsui Trust Group Inc. — 0.25%
  6. Pictet Asset Management Holding SA — 0.24%
Learn More about top institutional investors of Alnylam Pharmaceuticals stock.

Which major investors are selling Alnylam Pharmaceuticals stock?

In the last quarter, ALNY stock was sold by these institutional investors:
  1. Gabelli Funds LLC
  2. Baillie Gifford & Co.
  3. Pictet Asset Management Holding SA
  4. Assenagon Asset Management S.A.
  5. Allspring Global Investments Holdings LLC
  6. Jennison Associates LLC
  7. Aberdeen Group plc
  8. Handelsbanken Fonder AB
During the last year, company insiders that have sold Alnylam Pharmaceuticals company stock include:
  1. Yvonne Greenstreet (CEO)
  2. Jeffrey V Poulton (EVP)
  3. Jeffrey V Poulton (CFO)
  4. Tolga Tanguler (EVP)
  5. Kevin Joseph Fitzgerald (EVP)
  6. Pushkal Garg (EVP)
  7. Pushkal Garg (CMO)
  8. Michael W Bonney (Director)
  9. Amy W Schulman (Director)
  10. Dennis A Ausiello (Director)
Learn More investors selling Alnylam Pharmaceuticals stock.

Which major investors are buying Alnylam Pharmaceuticals stock?

In the previous quarter, ALNY stock was acquired by institutional investors including:
  1. FengHe Fund Management Pte. Ltd.
  2. ProShare Advisors LLC
  3. Congress Asset Management Co.
  4. Massachusetts Financial Services Co. MA
  5. KBC Group NV
  6. SG Americas Securities LLC
  7. Zurcher Kantonalbank Zurich Cantonalbank
  8. Mirae Asset Global Investments Co. Ltd.